Clinical Trial Update: Venetoclax Combined With Homoharringtonine and Cytarabine in Induction for AML [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating venetoclax with homoharringtonine and cytarabine for induction in acute myeloid leukemia, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Homoharringtonine (homoharringtonine)
• Venetoclax (venetoclax)

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Acute Myeloid Leukemia | Phase 2, Phase 3 | Status: RECRUITING